Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High Dose Ascorbic Acid + Chemo in Metastatic Pancreatic Cancer
NCT03697239Phase 2Withdrawn
- Start
- Jun 2019
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ascorbic acid in pancreatic ductal adenocarcinoma (PDAC). Planned start Jun 2019; status: withdrawn.
02
Drugs
ascorbic acid
03
Conditions
pancreatic ductal adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT03697239.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03697239.